The Breast Cancer Committee of the Chinese Society of Clinical Oncology (CSCO BC) has developed the CSCO Breast Cancer Diagnosis and Treatment Guidelines (hereafter referred to as the CSCO BC Guidelines), which have become a crucial reference for Chinese clinicians, serving as a "navigation tool" for clinical decision-making. With the rapid progress of clinical oncology, especially the continuous emergence of original Chinese research and treatment strategies, the CSCO BC Guidelines have not only stayed at the forefront of international developments but have also incorporated more "Chinese characteristics." This has attracted increasing attention from international experts. Recently, the English version of the CSCO BC Guidelines was published in the Translational Breast Cancer Research (TBCR), further showcasing China's experience and wisdom in breast cancer management to the global oncology community. Oncology Frontier invited Dr. Zefei Jiang, Dr. Chunfang Hao, Dr. Xu Liang, Dr. Jin Yang, Dr. Min Yan, and Dr. Yueping Liu to provide an overview of the key updates to the CSCO BC Guidelines and share their insights with international peers through this global platform.
